Resource ValueSet/FHIR Server from package us.nlm.vsac#0.21.0 (125 ms)
Package | us.nlm.vsac |
Type | ValueSet |
Id | Id |
FHIR Version | R4 |
Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1160.70/expansion |
Url | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.70 |
Version | 20241016 |
Status | active |
Date | 2024-10-16T01:07:54-04:00 |
Name | VasodilatorForHypertension |
Title | Vasodilator for Hypertension |
Experimental | False |
Realm | us |
Authority | hl7 |
Purpose | (Clinical Focus: The purpose of this value set is to represent concepts that represent medications in the Vasodilator pharmacologic class that are specifically indicated for the treatment of essential hypertension.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use, and prescribable medications of the Vasodilator pharmacologic class with a Semantic Clinical Drug (SCD) or Generic Pack (GPCK) term type that have a route of administration of: oral/pill, oral suspension, injectables, and transdermal.),(Exclusion Criteria: Excludes concepts that represent medications in the Vasodilator pharmacologic class with a route of administration of: ophthalmic, topical, foams, creams, and shampoo.) |
Resources that use this resource
Resources that this resource uses
Source
{
"resourceType" : "ValueSet",
"id" : "2.16.840.1.113762.1.4.1160.70",
"meta" : {
"versionId" : "8",
"lastUpdated" : "2024-11-26T11:15:11.000-05:00",
"profile" : [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail" : {
"name" : "HSAG Author"
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate" : "2024-10-16"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate" : "2024-10-16"
}
],
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.70",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113762.1.4.1160.70"
}
],
"version" : "20241016",
"name" : "VasodilatorForHypertension",
"title" : "Vasodilator for Hypertension",
"status" : "active",
"date" : "2024-10-16T01:07:54-04:00",
"publisher" : "American Medical Association Steward",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US"
}
]
}
],
"purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts that represent medications in the Vasodilator pharmacologic class that are specifically indicated for the treatment of essential hypertension.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use, and prescribable medications of the Vasodilator pharmacologic class with a Semantic Clinical Drug (SCD) or Generic Pack (GPCK) term type that have a route of administration of: oral/pill, oral suspension, injectables, and transdermal.),(Exclusion Criteria: Excludes concepts that represent medications in the Vasodilator pharmacologic class with a route of administration of: ophthalmic, topical, foams, creams, and shampoo.)",
"compose" : {
"include" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept" : [
{
"code" : "197986",
"display" : "minoxidil 10 MG Oral Tablet"
},
{
"code" : "197987",
"display" : "minoxidil 2.5 MG Oral Tablet"
},
{
"code" : "905199",
"display" : "hydralazine hydrochloride 10 MG Oral Tablet"
},
{
"code" : "905211",
"display" : "hydralazine hydrochloride 25 MG / hydrochlorothiazide 25 MG Oral Capsule"
},
{
"code" : "905217",
"display" : "hydralazine hydrochloride 50 MG / hydrochlorothiazide 50 MG Oral Capsule"
},
{
"code" : "905222",
"display" : "hydralazine hydrochloride 100 MG Oral Tablet"
},
{
"code" : "905225",
"display" : "hydralazine hydrochloride 25 MG Oral Tablet"
},
{
"code" : "905377",
"display" : "hydralazine hydrochloride 37.5 MG / isosorbide dinitrate 20 MG Oral Tablet"
},
{
"code" : "905395",
"display" : "hydralazine hydrochloride 50 MG Oral Tablet"
},
{
"code" : "966571",
"display" : "1 ML hydralazine hydrochloride 20 MG/ML Injection"
}
]
}
]
},
"expansion" : {
"identifier" : "urn:uuid:24ba1bd5-5733-477c-b8b0-fbdde29be005",
"timestamp" : "2024-12-10T07:17:53-05:00",
"total" : 10,
"contains" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "197986",
"display" : "minoxidil 10 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "197987",
"display" : "minoxidil 2.5 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "905199",
"display" : "hydralazine hydrochloride 10 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "905211",
"display" : "hydralazine hydrochloride 25 MG / hydrochlorothiazide 25 MG Oral Capsule"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "905217",
"display" : "hydralazine hydrochloride 50 MG / hydrochlorothiazide 50 MG Oral Capsule"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "905222",
"display" : "hydralazine hydrochloride 100 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "905225",
"display" : "hydralazine hydrochloride 25 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "905377",
"display" : "hydralazine hydrochloride 37.5 MG / isosorbide dinitrate 20 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "905395",
"display" : "hydralazine hydrochloride 50 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "966571",
"display" : "1 ML hydralazine hydrochloride 20 MG/ML Injection"
}
]
},
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.